Dow Jones

38 686,32

1,51%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Pathfinder Cell Therapy Inc (CE) (PFND)
Pathfinder Cell Therapy Inc (CE) (PFND) Actualités

PFND

Pathfinder Cell Therapy (CE) (PFND)

Pathfinder Cell Therapy Inc (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:PFND

Date	Heure	Source	Titre	Symbole	Société
05/04/2016	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
30/03/2016	22h16	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
29/03/2016	23h26	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
29/03/2016	21h26	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
29/03/2016	19h40	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
13/11/2015	17h23	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
31/03/2015	18h19	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
27/05/2014	22h25	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
29/04/2014	19h39	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
31/03/2014	21h52	Edgar (US Regulatory)	Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
14/08/2013	21h13	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
06/03/2013	23h33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
15/01/2013	14h28	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
28/12/2012	17h01	Edgar (US Regulatory)	Semi-annual Report (management Company) (nsar-a)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
07/12/2012	19h04	Edgar (US Regulatory)	Certified Annual Shareholder Report for Management Investment Companies (n-csr)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
15/05/2012	16h26	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
30/04/2012	20h06	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
30/03/2012	18h40	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
21/02/2012	14h01	GlobeNewswire Inc.	Pathfinder Presents Preliminary Data on New Regenerative Approach to Diabetes Treatment	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
16/02/2012	14h00	GlobeNewswire Inc.	Pathfinder to Present at New York Stem Cell Summit	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
15/02/2012	14h00	GlobeNewswire Inc.	Pathfinder Announces First European Patent Allowance for Pathfinder Cells	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
06/01/2012	00h13	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
16/12/2011	22h34	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
16/12/2011	00h31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
13/12/2011	16h00	GlobeNewswire Inc.	Pathfinder Cell Therapy Provides Update on Pathfinder Cell Research and Development	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
15/11/2011	23h13	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)
03/10/2011	22h44	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:PFND	Pathfinder Cell Therapy Inc (CE)